These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17308143)

  • 21. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ
    Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease.
    Dawson AJ; Sathyapalan T; Smithson JA; Vince RV; Coady AM; Ajjan R; Kilpatrick ES; Atkin SL
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):843-9. PubMed ID: 23746214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
    Chang AY; Wild RA
    Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk in women with polycystic ovary syndrome.
    Cho LW; Atkin SL
    Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment.
    Jakubowska J; Bohdanowicz-Pawlak A; Milewicz A; Szymczak J; Bednarek-Tupikowska G; Demissie M
    Gynecol Endocrinol; 2008 Jul; 24(7):378-84. PubMed ID: 18645710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum markers of vascular inflammation in dyslipemia.
    Francisco G; Hernández C; Simó R
    Clin Chim Acta; 2006 Jul; 369(1):1-16. PubMed ID: 16469304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study.
    Palomba S; Falbo A; Chiossi G; Orio F; Tolino A; Colao A; La Sala GB; Zullo F
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2942-51. PubMed ID: 24873996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indices of low-grade chronic inflammation correlate with early cognitive deterioration in an elderly Greek population.
    Dimopoulos N; Piperi C; Salonicioti A; Mitropoulos P; Kallai E; Liappas I; Lea RW; Kalofoutis A
    Neurosci Lett; 2006 May; 398(1-2):118-23. PubMed ID: 16426755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndrome.
    Xiong YL; Liang XY; Yang X; Li Y; Wei LN
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):148-50. PubMed ID: 21908093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome.
    Orio F; Palomba S; Cascella T; Di Biase S; Manguso F; Tauchmanovà L; Nardo LG; Labella D; Savastano S; Russo T; Zullo F; Colao A; Lombardi G
    J Clin Endocrinol Metab; 2005 Jan; 90(1):2-5. PubMed ID: 15483098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia.
    Kanavaki I; Makrythanasis P; Lazaropoulou C; Tsironi M; Kattamis A; Rombos I; Papassotiriou I
    Blood Cells Mol Dis; 2009; 43(3):230-4. PubMed ID: 19654073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease.
    Oktem M; Ozcimen EE; Uckuyu A; Esinler I; Pamuk B; Bayraktar N; Kulaksizoglu S; Zeyneloglu HB
    Fertil Steril; 2009 Jun; 91(6):2545-50. PubMed ID: 18554599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease.
    Boulman N; Levy Y; Leiba R; Shachar S; Linn R; Zinder O; Blumenfeld Z
    J Clin Endocrinol Metab; 2004 May; 89(5):2160-5. PubMed ID: 15126536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.
    Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Blaak EE; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
    Eur J Clin Invest; 2009 Jun; 39(6):437-44. PubMed ID: 19397692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term consequences of polycystic ovary syndrome on cardiovascular risk.
    Rizzo M; Berneis K; Spinas G; Rini GB; Carmina E
    Fertil Steril; 2009 Apr; 91(4 Suppl):1563-7. PubMed ID: 18976752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of novel biomarkers of inflammation in patients with stable coronary heart disease.
    Oren H; Erbay AR; Balci M; Cehreli S
    Angiology; 2007; 58(2):148-55. PubMed ID: 17495262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances.
    Karadeniz M; Erdoğan M; Tamsel S; Zengi A; Alper GE; Cağlayan O; Saygili F; Yilmaz C
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):231-5. PubMed ID: 18393129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.